Edwards Lifesciences (EW) Goodwill (2009 - 2026)

Edwards Lifesciences has reported Goodwill for 18 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Goodwill rose 2.3% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 2.3% YoY), and the FY2025 full-year result was $1.8 billion, changed 0.46% from the prior year.
• Goodwill for Q1 2026 stood at $1.8 billion, up from $1.8 billion in the prior quarter.
• The five-year high for Goodwill was $1.8 billion in Q1 2026, with the low at $1.1 billion in Q4 2022.
• Average Goodwill over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2023.
• Peak annual rise in Goodwill reached 55.16% in 2024, while the deepest fall reached 11.43% in 2024.
• Tracing EW's Goodwill over 5 years: stood at $1.1 billion in 2022, then grew by 7.54% to $1.1 billion in 2023, then soared by 55.16% to $1.8 billion in 2024, then retreated by 0.46% to $1.8 billion in 2025, then advanced by 2.88% to $1.8 billion in 2026.
• The last three Goodwill figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.

Peer Comparison